Back |
home / stock / adxn / adxn message board
Subject | By | Source | When |
---|---|---|---|
Sold most at 1.37, then the rest 1.33 today. | SubPennyBoater | investorshub | 08/05/2022 8:48:42 PM |
Bought at 1.25, should see 2$ soon | SubPennyBoater | investorshub | 08/05/2022 12:04:59 AM |
$ADXN$$ Moving Higher!! | tickersym | investorshub | 07/27/2022 12:33:51 PM |
I can totally understand what you say and | subslover | investorshub | 07/23/2022 12:31:33 AM |
lol 18 months later...I was just tracking panic | dealerschool2006 | investorshub | 07/22/2022 8:07:17 PM |
Doesnt look to positive right now | Odiwon | investorshub | 07/22/2022 1:26:55 PM |
Addex Raises $4.2 million in Equity Financing | subslover | investorshub | 07/22/2022 12:27:21 PM |
znewcar1: ADXN 110% v158M c1.93 f6,31M H2.49 ML=LL=YL.86 | znewcar1 | investorshangout | 07/22/2022 3:50:53 AM |
znewcar1: LL.86 HH.37.52 @2.22 HOD2.48 S@1.5ish? | znewcar1 | investorshangout | 07/21/2022 6:11:19 PM |
Addex Provides Corporate Update and Financial Guidance | subslover | investorshub | 07/21/2022 12:23:43 PM |
Addex Completes Reduction in Nominal Value of Shares | subslover | investorshub | 07/21/2022 12:21:32 PM |
Bid under dollar now. | willlbone | investorshub | 06/17/2022 2:09:57 PM |
$ADXN finally going up... | dealerschool2006 | investorshub | 01/13/2021 7:54:43 PM |
$ADXN down from public offering news... | dealerschool2006 | investorshub | 01/07/2021 8:07:07 PM |
Monday's huge runner. | dinogreeves | investorshub | 12/24/2020 7:03:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Addex Therapeutics Ltd Company Name:
ADXN Stock Symbol:
NASDAQ Market:
Addex Therapeutics Ltd Website:
2024-07-19 15:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 15, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological...
Geneva, Switzerland, July 12, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that Mikhail Kalinichev, Head of T...